Metzger Monika L, Howard Scott C, Fu Ligia C, Peña Armando, Stefan Rene, Hancock Michael L, Zhang Zhe, Pui Ching Hon, Wilimas Judy, Ribeiro Raul C
Department of Hematology-Oncology and International Outreach Program, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
Lancet. 2003 Aug 30;362(9385):706-8. doi: 10.1016/S0140-6736(03)14228-6.
The causes of treatment failure in childhood acute lymphoblastic leukaemia are thought to differ between resource-rich and resource-poor countries. We assessed the records of 168 patients treated for this disease in Honduras. Abandonment of treatment (n=38), the main cause of failure, was associated with prolonged travel time to the treatment facility (2-5 h: hazard ratio 3.1, 95% CI 1.2-8.1 vs >5 h: 3.7, 1.3-10.9) and age younger than 4.5 years (2.6, 1.1-6.3). 35 patients died of treatment-related effects. Outcome could be substantially improved by interventions that help to prevent abandonment of therapy (such as funding for transport, satellite clinics, and support groups), and by prompt treatment of infection.
人们认为,资源丰富国家和资源匮乏国家儿童急性淋巴细胞白血病治疗失败的原因有所不同。我们评估了洪都拉斯168例接受该疾病治疗患者的记录。治疗中断(n = 38)是治疗失败的主要原因,与前往治疗机构的路途时间延长有关(2 - 5小时:风险比3.1,95%置信区间1.2 - 8.1;超过5小时:3.7,1.3 - 10.9)以及年龄小于4.5岁(2.6,1.1 - 6.3)。35例患者死于治疗相关影响。通过有助于防止治疗中断的干预措施(如交通资金、卫星诊所和支持小组)以及及时治疗感染,结局可能会得到显著改善。